Publications by authors named "Yangrui Peng"

Claim this Profile
D
Design and synthesis of novel -phenyl-4-pyrimidine-diamine BCL6 inhibitors with -tumor activities.
Yan Li, Yajing Xing, Dongxia Huang, Jiuqing Xie, Yangrui Peng

Future Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Synthesis of Functions-Integrated Hydrogel as a Self-Powered Wound Dressing for Real-Time Drug Release and Health Monitoring.
Haiyu Li, Hui Zhang, Yangrui Peng, Xinxin Liu, Jie Du

Adv Healthc Mater· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.
Haijun Gu, Ting Zhang, Tian Guan, Min Wu, Shen Li, Yangrui Peng

J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Pyrimidinediamine Derivatives as Potent Methuosis Inducers for the Treatment of Triple-Negative Breast Cancer.
Jia He, Luzhen Wang, DaZhao Mi, Tian Guan, Wenjing Liu, Peng He, Yangrui Peng

J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance.
Peng He, Juanjuan Feng, Xinting Xia, Yue Sun, Jia He, Yangrui Peng

J Med Chem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr/Ser Inhibitory Activity for Gastric Cancer Treatment.
Peng He, Ying Miao, Yue Sun, Aiwu Bian, Wangrui Jin, Yangrui Peng

J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective.
Haixiang Pei, Weikai Guo, Yangrui Peng, Hai Xiong, Yihua Chen

Med Res Rev· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis.
Wangrui Jin, Tao Zhang, Wenbo Zhou, Peng He, Yue Sun, Yangrui Peng

J Med Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.
Haijun Gu, Yangrui Peng, Yihua Chen

Curr Top Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent ureido tetrahydrocarbazole derivatives for cancer treatments through targeting tumor-associated macrophages.
Haixiang Pei, Juliang Qin, Fengmian Wang, Binghe Tan, Zeda Zhao, Yangrui Peng

Eur J Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery.
Haixiang Pei, Yangrui Peng, Qiuhua Zhao, Yihua Chen

RSC Adv· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of N-Substituted 2-(4-pyridinyl)thiazole carboxamides against Tumor Growth through Regulating Angiogenesis Signaling Pathways.
Wenbo Zhou, Wenshu Tang, Zhenliang Sun, Yunqi Li, Yanmin Dong, Yangrui Peng

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.
Feifei Yang, Shihong Peng, Yunqi Li, Liqiang Su, Yangrui Peng

Org Biomol Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway.
Cong Zheng, Yuanzhang Fang, Weiguang Tong, Guoliang Li, Haigang Wu, Peng Wang, Yangrui Peng

J Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis